Results 251 to 260 of about 2,934,165 (348)

[Alternatives of alternative medicine].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2000
R, Pedersen, B, Hofmann
openaire   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Role of community pharmacists in the safe and effective use of complementary and alternative medicine in the Middle East: A scoping review. [PDF]

PLoS One
Naja F, Ahmad M, Shatila H, Abu Shihab KHN, Naalbandian S, Saqan R, Alzubaidi H, Hijazi MA.   +7 more
europepmc   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Attitudes and use of complementary and alternative medicine: a cross-sectional comparison between medical and non-medical students. [PDF]

Front Pharmacol
Zakeri M, Dehghan M, Soltanmoradi Y, Monfared S, Kose G, Farahmandnia H, Hermis AH, Xu X, Zakeri MA.   +8 more
europepmc   +1 more source

PREVALENCE AND SATISFACTION LEVELS OF COMPLEMENTARY ALTERNATIVE MEDICINE USE FOR THE HEADACHES – A CROSS- SECTIONAL STUDY

Wajid Syed
openalex   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Cancer and alternative medicine

Journal of Anaesthesiology Clinical Pharmacology, 2010
Jayashree Sen
doaj  

Targeting inflammation, fibrosis, and vascular dysfunction in systemic sclerosis: the role of diet and complementary and alternative medicine. [PDF]

Curr Opin Rheumatol
Balbuena Hurtado V, Hinchcliff M, Murugesan N.   +2 more
europepmc   +1 more source

Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer

Molecular Oncology, EarlyView.
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta, Yang Song, Madeleine Ndahayo, Anirudh Saxena, Theresa Guo, Dylan Z. Kelley, Jessica Gore, Andrew Hennigan, Alexa Anderson, John C. Papadimitriou, Daria A. Gaykalova   +10 more
wiley   +1 more source